Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Respiratory/Pulmonary

1594

Pulmonary or respiratory medicine (a.k.a. pneumology) is the medical specialty concerned with the diagnosis and management of disorders of the lungs, upper airways, thoracic cavity and chest wall. Pulmonary medicine is a subspecialty of internal medicine. Pulmonologists are medical doctors that specialize in treating disorders related to the lungs and respiratory system.

A pulmonologist uses a number of tools to diagnose patients.

Pulmonary function tests are a group of tests that measure the lung capacity and efficiency of gas exchanges. Pulmonary function tests involve spirometry, which measures lung volume, diffusing capacity and flow volume loop. Other tests include: chest x-ray and CT scan, bronchoscopy, cardiopulmonary exercise test, lung and pleural biopsy, mediastinoscopy, pleural fluid analysis, pulmonary angiography, sleepy study and ventilation/perfusion lung scans.

Pulmonologists treat a wide variety of pulmonary diseases including asthma, emphysema, chronic bronchitis, lung cancer, cystic fibrosis, pneumonia, obstructive sleep apnea, rheumatologic lung diseases, obesity-hypoventilation syndrome and tuberculosis.

RSS Feeds

All reports in Respiratory/Pulmonary

< prev 1  2  3  4  5  6  7  8  9  10  next >
Triple Analysis: Lung Cancer, Angiogenesis and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides
5/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...  |  more...
$5,175.00
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... and data relating to the clinical trials on Bronchopulmonary Dysplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Lung Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... and data relating to the clinical trials on Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... scenario. This report provides elemental information and data relating to the clinical trials on Viral Respiratory Tract Infection. It includes an overview of the trial numbers and their recruitment status as per the site of ...  |  more...
$1,000.00
Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... provides elemental information and data relating to the clinical trials on Obstructive Pulmonary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ...  |  more...
$1,000.00
Respiratory Depression – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Respiratory Depression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Depression. 'Respiratory Depression - Pipeline Review, H1 2012' ...  |  more...
$500.00
Acute Respiratory Distress Syndrome – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute ...  |  more...
$500.00
Cough – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cough. 'Cough - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines
3/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
3/1/2012 | published by: BioSeeker Group AB
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Angiogenesis
3/1/2012 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Colorectal Cancer, Lung Cancer and Pancreatic Cancer
3/1/2012 | published by: BioSeeker Group AB
... assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. Below is a short ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Peptides
3/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
... The report is an essential source of information and analysis on the global Pulmonary Embolism Therapeutics market. The report identifies the key trends shaping and driving the global Pulmonary Embolism Therapeutics market. The report also ...  |  more...
$3,995.00
Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2/29/2012 | published by: GlobalData
... data on the Respiratory Devices market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within six market categories – Ventilators, Positive Airway ...  |  more...
$2,500.00
Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Pulmonary Fibrosis. 'Idiopathic Pulmonary ...  |  more...
$500.00
Pneumonia – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pneumonia. 'Pneumonia - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Bronchitis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchitis. 'Bronchitis - Pipeline Review, H1 2012' is built using data and information ...  |  more...
$500.00
Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...  |  more...
$500.00
Analytical Tool - Lung Cancer
2/21/2012 | published by: BioSeeker Group AB
... analytical studies, the therapeutic lung cancer drug market is predicted to exceed $4 billion between 2010 and 2015. Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012; Aventis’ ...  |  more...
$4,650.00
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019
1/31/2012 | published by: GlobalData
... to 2019”. The report is an essential source of information and analysis on the global Respiratory Syncytial Virus (RSV) Prophylactic market. The report identifies the key trends shaping and driving the global Respiratory Syncytial Virus ...  |  more...
$3,995.00
Acute Lung Injury - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... the therapeutic development for Acute Lung Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Lung Injury. 'Acute Lung ...  |  more...
$500.00
< prev 1  2  3  4  5  6  7  8  9  10  next >